loading

Zentalis Pharmaceuticals Inc (ZNTL) 最新ニュース

pulisher
03:59 AM

Thrivent Financial for Lutherans Grows Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

03:59 AM
pulisher
Apr 03, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Hold” by Brokerages - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Zentalis Strengthens Team with $194,600 in Equity Incentives - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Virtu Financial LLC Buys Shares of 24,973 Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Leerink Partnrs Issues Pessimistic Outlook for ZNTL Earnings - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

What is HC Wainwright’s Forecast for ZNTL Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Leerink Partnrs Has Pessimistic Outlook of ZNTL Q1 Earnings - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Wedbush Reiterates Neutral Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals: Hold Rating Amid Clinical Progress and Financial Uncertainty - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Bank of New York Mellon Corp Sells 10,375 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Receives “Buy” Rating from HC Wainwright - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Zentalis Pharmaceuticals Reports Progress and Financials - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Stifel maintains Buy on Zentalis stock with $9 target By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

H.C. Wainwright sets $10 target for Zentalis shares, maintains Buy By Investing.com - Investing.com Canada

Mar 27, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc Reports Annual EPS of -$2.33, Excee - GuruFocus

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 MillionSEC Filing - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Zentalis Breakthrough: 35% Response Rate in Ovarian Cancer Trial Wins FDA Fast Track - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

Zentalis Pharmaceuticals to Present Multiple Posters at the - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

Major Cancer Breakthrough: Zentalis Reveals New Azenosertib Data Across Multiple Tumor Types - Stock Titan

Mar 25, 2025
pulisher
Mar 21, 2025

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 20, 2025

Zentalis pharmaceuticals director Luke Walker buys $24,966 in stock - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Earns Buy Rating from HC Wainwright - The AM Reporter

Mar 19, 2025
pulisher
Mar 17, 2025

H.C. Wainwright maintains $10 target on Zentalis stock By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Zentalis Highlights Promising Azenosertib Data at SGO 2025 - TipRanks

Mar 17, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at - GlobeNewswire

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - MarketScreener

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Announces Updated Clinical Data From Part 1b Of DENALI Trial Of Azenosertib In PROC - Nasdaq

Mar 15, 2025
pulisher
Mar 15, 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - TradingView

Mar 15, 2025
pulisher
Mar 11, 2025

Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) Has Been Trading Down. What Are The Prospects For The Future? - stocksregister.com

Mar 11, 2025
pulisher
Mar 09, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Brokerages - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

ZNTL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Zentalis Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 03, 2025

How Zentalis Is Attracting Talent: Inside Their Latest Employee Compensation Package - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Zentalis Pharmaceuticals Announces Multiple Data - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

Can Zentalis's Azenosertib Change Treatment Landscape for Resistant Ovarian Cancer? - Stock Titan

Mar 03, 2025
pulisher
Feb 27, 2025

A company insider recently bought 20,000 shares of Zentalis Pharmaceuticals Inc [ZNTL]. Should You Buy? - Knox Daily

Feb 27, 2025
pulisher
Feb 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc.ZNTL - PR Newswire

Feb 25, 2025
pulisher
Feb 24, 2025

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Can Zentalis' Novel Cancer Drug Pipeline Impress at Two Elite Healthcare Conferences? - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Zentalis Pharmaceuticals (ZNTL) Projected to Post Quarterly Earnings on Tuesday - The AM Reporter

Feb 23, 2025
pulisher
Feb 22, 2025

Zentalis stock price target cut to $10 by H.C. Wainwright - MSN

Feb 22, 2025
pulisher
Feb 22, 2025

Zentalis pharmaceuticals officer sells $24,590 in stock - MSN

Feb 22, 2025
pulisher
Feb 21, 2025

Zentalis Pharmaceuticals (ZNTL): Among Cheapest Stocks Insiders Are Buying Recently - Yahoo Finance

Feb 21, 2025
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):